Stem cell therapy for liver disease including cirrhosis and fatty liver. MSC treatments repair liver damage, reduce fibrosis, and help restore healthy liver function.
Stem cell therapy for liver disease at StemCell Longevita in Istanbul, Turkey promotes liver regeneration, reduces fibrosis, and restores hepatic function. Our MSC treatments help patients with liver cirrhosis, fatty liver disease (NAFLD/NASH), liver fibrosis, and alcoholic liver disease achieve measurable improvements in liver function without transplantation.
MSCs home to damaged liver tissue where they differentiate into hepatocyte-like cells, reduce hepatic inflammation, reverse fibrosis by inhibiting hepatic stellate cell activation, and promote regeneration of functional liver tissue. They also improve portal circulation, reduce liver-related ascites, and support overall metabolic function. Clinical trials published in Hepatology demonstrate improved MELD scores and liver function tests after MSC therapy.
Candidates include patients with compensated and decompensated liver cirrhosis, non-alcoholic fatty liver disease (NAFLD/NASH), alcoholic liver disease, liver fibrosis, and those on transplant waiting lists seeking to stabilize or improve liver function. Patients with Child-Pugh class A-B cirrhosis typically show the strongest response.
After review of liver function tests, fibroscan/elastography results, and imaging, treatment involves systemic IV MSC infusion. The liver's rich blood supply naturally captures a significant proportion of IV-infused MSCs, making this an effective delivery route for hepatic conditions.
Improvements in liver function tests (ALT, AST, albumin, bilirubin) typically within 1-3 months. Fibrosis reduction visible on fibroscan at 3-6 months. Patients may experience improved energy, reduced ascites, better appetite, improved coagulation markers, and enhanced overall liver function. MELD score improvements have been documented.
Turkey has a strong tradition in hepatology and liver transplantation. Our regenerative liver protocols offer an alternative or bridge to transplant at costs 60-80% lower than Western countries. Our GMP lab produces MSCs optimized for hepatic regeneration.
Liver disease stem cell therapy from €6,950, including liver function assessment, fibroscan, MSC infusion, hotel accommodation, VIP transfers, and 12-month hepatic follow-up.
Related treatments: Diabetes Stem Cell Therapy | Hepatitis Stem Cell Therapy | COPD Stem Cell Therapy | Pulmonary Fibrosis Stem Cell Therapy | Kidney Disease Stem Cell Therapy
Pillar: stem cell therapy for liver disease in Istanbul
Related treatments: hepatitis stem cell treatment in Istanbul | diabetes stem cell therapy in Turkey | kidney disease MSC treatment in Istanbul | COPD stem cell therapy in Turkey
Research & guides: MSC therapy for diabetes management in Turkey | stem cell treatment for liver cirrhosis and fibrosis in Istanbul